Part I: Accurately Diagnosing Alzheimer’s Disease: Shortcomings of Blood Biomarkers and Need for Definitive, Non-invasive Diagnostic Testing

Author of publication Dr. Daniel Alkon, chief scientific advisor, SDx
Synaps Dx